14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 154 days ( -157.09 % )
Last Price $68.49 0 %
High/ Low $68.49 - $68.49 0%
Chg 7 Days N/A $68.49 $68.49
Chg 30 Days N/A $68.49 $68.49
Chg 12 mos 166.71 % $25.68 $68.49
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos 163.53 % Width: 58.22 %
Pred. range - 3 mos $68.49 - $68.49 0 % - 0 %
Pred. range - 12 mos $151.72 - $240.06 121.52 % - 250.50 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Sep 23, 2022 - 87 days
Long MA avg 12 mos Buy Jun 28, 2022 - 148 days
Short/Long MA avg 12 mos Buy Jul 01, 2022 - 145 days
Pivot Short Sell Jan 26, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT